| Rank | Symbol | Company | Insider's Name | Role | Market Cap | Avg. Return | ||
|---|---|---|---|---|---|---|---|---|
| TERN | Terns Pharmaceuticals Inc | Andrew Gengos | Chief Financial Officer | $3.24B | 1,045.81% | |||
| JANX | Janux Therapeutics Inc | Tighe Reardon | Acting Chief Financial Officer | $910.64M | 751.96% | |||
| SEZL | Sezzle Inc. | Charles Youakim | Executive Chairman and CEO | $2.32B | 585.09% | |||
| MNPR | Monopar Therapeutics Inc | Andrew Cittadine | Chief Operating Officer | $481.08M | 525.00% | |||
| CRVS | Corvus Pharmaceuticals Inc | Richard A. Miller MD | President and CEO | $1.91B | 433.53% | |||
| CRVS | Corvus Pharmaceuticals Inc | William Benton Jones | See Remarks | $1.91B | 433.53% |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
